loader from loading.io

Addressing Racial Trauma through Psychedelic Therapy with Monnica T. Williams, PhD, ABPP

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

Release Date: 06/25/2025

Psychedelics and Religion with Hunt Priest, MDiv show art Psychedelics and Religion with Hunt Priest, MDiv

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

In this episode, Hunt Priest joins to discuss the intersection of psychedelic experiences and religion. Hunt is the founder of Ligare: A Christian Psychedelic Society and was a participant in the Johns Hopkins/NYU Psilocybin Study for Religious Leaders in 2016. The epiphanies he had at Hopkins forever changed the trajectory of his work and led him to start Ligare in 2021. In this conversation, Hunt Priest reflects on how participating in the Johns Hopkins study reshaped his understanding of Christianity, embodiment, and spiritual experience. Drawing on his background as an Episcopal priest, he...

info_outline
Encore Episode: How Psychedelics Affect the Brain with Manesh Girn, PhD show art Encore Episode: How Psychedelics Affect the Brain with Manesh Girn, PhD

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

In this encore episode of the Psychedelic Medicine Podcast, psychedelic science researcher and educator Dr. Manesh Girn discusses his studies investigating psychedelic brain action. Manesh earned PhD in neuroscience at McGill University and is an author on over a dozen peer-reviewed articles on psychedelics and related topics. He is also chief research officer at EntheoTech Bioscience and runs the YouTube channel the Psychedelic Scientist.  In this conversation, Manesh discusses his recent article in Trends in Cognitive Sciences titled He explains the complexity science approach used...

info_outline
Which Psychedelic for Which Condition? with Will Van Derveer, MD show art Which Psychedelic for Which Condition? with Will Van Derveer, MD

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

In this episode, Will Van Derveer, MD joins to unpack what we know about which psychedelic medicines are best suited to particular mental health conditions. Dr. Van Derveer has trained several thousand mental health professionals in psychedelic-assisted psychotherapy, provided ketamine assisted therapy to hundreds of people, and has staffed MDMA therapy trials with MAPS. His book, Psychedelic Therapy: A Revolutionary Approach to Restoring Your Mental Health and Reclaiming Your Life, will be published by Shambala in the spring of 2026. In this conversation, Dr. Van Derveer offers a...

info_outline
Psychedelics for the Menopause Transition with Alicia Bigelow, ND show art Psychedelics for the Menopause Transition with Alicia Bigelow, ND

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

In this episode, Alicia Bigelow, ND joins to discuss the potential of psychedelic medicine to support the menopause transition. Dr. Ali Bigelow is a naturopathic physician, ketamine provider and licensed psilocybin facilitator in Portland, OR. She leads individual and group retreats, enjoys incorporating live music into her sessions when desired, and is passionate about supporting those navigating life transitions, such as end of life and menopause, through her low dose group, Menomorphosis. Dr. Bigelow will be doing retreats in 2026 with Rise Up Journeys at In this conversation, Dr. Bigelow...

info_outline
Psychedelics as Catalysts for Human Agency with Matthew W. Johnson, PhD show art Psychedelics as Catalysts for Human Agency with Matthew W. Johnson, PhD

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

In this episode, Matthew W. Johnson, PhD returns to discuss how psychedelics can be leveraged to catalyze human agency. Dr. Johnson has been at the forefront of psychedelic research for 21 years, having conducted seminal research on the effects of psilocybin on mystical experience, personality, and treatment of cancer distress, major depressive disorder, and tobacco addiction. His work with tobacco addiction received the first federal funding for a classic psychedelic in the modern era of research. In this conversation, Dr. Johnson explores psychedelics as powerful enhancers of human...

info_outline
Psychedelics and Movement with Dmitry Repin, PhD show art Psychedelics and Movement with Dmitry Repin, PhD

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

In this episode, Dmitry Repin, PhD joins to discuss the intersection of bodily movement and psychedelics. Dr. Repin is the co-founder of the Institute for Psychedelic Research at Tel Aviv University, holds a PhD in cognitive neuroscience, and is the producer and creative force behind the . In this conversation, Dr. Repin explores how psychedelics may influence movement, proprioception, and motor learning, drawing from his background in neuroscience and his transformative experiences with dance practices like . He describes his team’s innovative clinical study pairing psilocybin with guided...

info_outline
Psychedelic Medicine: Updates from the field with Lynn Marie Morski, JD, MD show art Psychedelic Medicine: Updates from the field with Lynn Marie Morski, JD, MD

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

In this episode, Psychedelic Medicine Podcast host, Dr. Lynn Marie Morski, provides the latest updates from the field of psychedelic medicine. Dr. Morski discusses the breakthrough therapy designation which a number of psychedelic compounds have received in the past few years, the most recent of which is BPL-003, a nasal spray formulation of 5-MeO-DMT. One of the exciting aspects of this new compound, Dr. Morski notes, is that it is shorter-acting than most serotonergic psychedelics—a feature which may make treatment with this substance less expensive and more accessible.  Another...

info_outline
Psilocybin-Assisted Group Therapy for Depression with Matthew Hicks, ND, MS show art Psilocybin-Assisted Group Therapy for Depression with Matthew Hicks, ND, MS

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

In this episode Matthew Hicks, ND, MS joins to dive into the topic of psilocybin-assisted group therapy for depression. Dr. Hicks is a research Investigator at the National University of Natural Medicine as well as a Naturopathic doctor and licensed psilocybin facilitator at Synaptic Institute. In this conversation, Dr. Hicks shares findings from one of the first studies investigating psilocybin-assisted group therapy for depression, conducted in Oregon’s new legal psilocybin framework. He explains how the high cost and labor-intensive nature of psychedelic therapy inspired him to explore a...

info_outline
Microdosing Psilocybin: Truth vs Hype with Rotem Petranker, PhD show art Microdosing Psilocybin: Truth vs Hype with Rotem Petranker, PhD

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

In this episode Rotem Petranker, PhD joins to discuss the current state of research on microdosing psilocybin. Dr. Petranker is the co-founder of the Psychedelic Studies Research Program at the University of Toronto and the Canadian Centre for Psychedelic Science. He recently ran the world's largest randomized controlled trial on the effectiveness of microdosing psilocybin on Major Depressive Disorder. In this conversation, Dr. Petranker shares insights from running the world’s largest randomized controlled trial on psilocybin microdosing for major depressive disorder. He explains the...

info_outline
Encore Episode: Exploring Endogenous DMT with Rick Strassman, MD show art Encore Episode: Exploring Endogenous DMT with Rick Strassman, MD

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

In this episode of the Psychedelic Medicine Podcast, Rick Strassman, MD joins to discuss the topic of endogenous DMT. Dr. Strassman is adjunct associate professor of psychiatry at the University of New Mexico in Albuquerque and author of and . His DMT and psilocybin studies in the early 1990s initiated the renewal of human research with psychedelics in the U.S. In this conversation, Dr. Strassman discusses the finer details of DMT, from endogenous production in humans and animals, to visionary experiences and theological implications. Dr. Strassman also covers the research that's been done...

info_outline
 
More Episodes

In this episode, Monnica T. Williams, PhD, ABPP joins to discuss how psychedelics may help alleviate mental health impacts of racial trauma. Dr. Williams is a licensed clinical psychologist and professor at the University of Ottawa in the School of Psychology, where she is the Canada Research Chair in Mental Health Disparities.

In this conversation, Dr. Williams begins by highlighting the daily stress and trauma experienced by people of color, likening it to PTSD. She discusses a survey her team conducted which revealed that many people of color use psychedelics to manage racial trauma, showing significant reductions in stress, depression, and anxiety. Additionally, Dr. Williams emphasizes the importance of a safe environment and culturally competent therapists. In closing, she discusses ongoing research at this intersection and the need for more funding and awareness in this field.

 

In this episode, you'll hear:

  • How racial trauma manifests as conditions like PTSD, depression, and anxiety
  • The importance of an intersectional perspective
  • Current treatments for mental health struggles stemming from racial trauma
  • Results from Dr. Williams’ research into psychedelic use amongst people of color
  • The importance of safe and supportive settings for psychedelic experiences
  • How shared life experiences between a therapist and client can strength the therapeutic alliance and improve outcomes
  • Why bias training is particularly important in the context of psychedelic therapy

 

Quotes:

“People of color who live in these white dominated Western contexts are continually bombarded by subtle —and not so subtle—messages about their worth, about their standing in society, about their intelligence, their character, on and on and on and on. And so really the daily onslaught just wears and wears away at people, and the stress of that can actually become traumatizing.” [1:49]

“People heal from trauma when someone witnesses their pain, right? When people can compassionately witness your pain and join in it with you—this is the basis behind all therapeutic approaches for trauma treatment.” [10:13]

“We saw [from our survey study] that many, many people of color are using psychedelics to manage racism, often very quietly. But it seems for many people to be quite effective and quite helpful.” [11:53]

“We looked at some separate psychedelics where we had enough people who described a specific one like psilocybin or LSD or peyote in some cases. And so we were able to look at those psychedelics separately and we didn't actually find a difference. It didn't seem to matter which psychedelic it was. It seemed that they were all, more or less equally effective.” [15:20]

 

Links:

Dr. Williams’ website

Dr. Williams on X

Dr. Williams on Instagram

Dr. Williams on LinkedIn

Dr. Williams’ study “Investigating the associations of acute psychedelic experiences and changes in racial trauma symptoms, psychological flexibility, and substance use among People with Racial and Ethnic Minoritized Identities in the United States and Canada”

Behavioral Wellness Clinic - Connecticut

Behavioural Wellness Clinic - Ottawa 

Masters Program in Psychedelics and Consciousness Studies at University of Ottawa

Psychedelic Medicine Association

Porangui